Elsevier

JAAD Case Reports

Volume 24, June 2022, Pages 74-77
JAAD Case Reports

Case report
A case of pityriasis rubra pilaris following AstraZeneca COVID-19 vaccine

https://doi.org/10.1016/j.jdcr.2022.04.020Get rights and content
Under a Creative Commons license
open access

Key words

adverse effect
ChAdOx1 COVID-19 vaccine
COVID-19
cutaneous adverse effect
erythroderma
pityriasis rubra pilaris
vaccine

Abbreviations used

AZ
AstraZeneca ChAdOx1 nCoV-19 Vaxzevria vaccine
PRP
pityriasis rubra pilaris

Cited by (0)

Funding sources: None.

IRB approval status: Not applicable.